Quinoline

Quinoline

SCHEMBL5260404

O=S(=O)(O)C(F)(F)F.c1ccc2ncccc2c1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.61
KDM4E B2RXH2 3/20 0.46
ALOX12 P18054 1/20 0.46
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
CASP1 P29466 2/20 0.42
CASP7 P55210 1/20 0.42
NPC1 O15118 2/20 0.40
POLB P06746 2/20 0.40
RAB9A P51151 1/20 0.40
MAPT P10636 2/20 0.39
CYP3A4 P08684 1/20 0.39
NAMPT P43490 1/20 0.39
BCAT1 P54687 1/20 0.39
ALPL P05186 1/20 0.38
HTT P42858 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
NR4A2 P43354 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Quinoline SCHEMBL28462226 0.98 ALDH1A1 (0.59) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL28462227 0.98 ALDH1A1 (0.59) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL27844305 0.87 ALDH1A1 (0.68) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL29710686 0.87 ALDH1A1 (0.74) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL28142303 0.87 ALDH1A1 (0.74) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL5874241 0.87 ALDH1A1 (0.74) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL21535 0.87 ALDH1A1 (0.74) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL28261411 0.87 ALDH1A1 (0.74) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL28001767 0.86 ALDH1A1 (0.61) ALDH1A1KDM4EALOX12MEN1KMT2A
Quinoline SCHEMBL3914666 0.85 ALDH1A1 (0.71) ALDH1A1KDM4EALOX12MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101948429-B 1-methyl-7H-indene[1, 2-b]quinolinetrifluoromesylate-7-(4-dimethylamino) benzyl alkene derivant and preparation thereof UNIV SOOCHOW 2012-07-18 CN claimed
CN-101948429-A 1-methyl-7H-indene[1, 2-b]quinolinetrifluoromesylate-7-(4-dimethylamino) benzyl alkene derivant and preparation thereof UNIV SUZHOU 2011-01-19 CN claimed
US-5220106-A Organic non-quaternary clathrate salts for petroleum separation EXXON RESEARCH AND ENGINEERING COMPANY (US) 1993-06-15 US claimed
CN-111909085-B Fluorescent probe for detecting sulfur dioxide derivative, detection object, preparation method and application 衡阳师范学院 2023-07-18 CN disclosed
CN-109851554-B Method for preparing trifluoromethanesulfonic acid-6-quinoline ester derivative 中国科学院大连化学物理研究所 2022-05-17 CN disclosed
CN-111909085-A Fluorescent probe for detecting sulfur dioxide derivative, detector, preparation method and application 衡阳师范学院 2020-11-10 CN disclosed
CN-107709393-A Reaction product containing urethane group and urea groups 毕克化学有限公司 2018-02-16 CN disclosed
CN-101948382-B Synthetic method of 2-(4-alkyl substituted benzoyl) phenylformic acid UNIV ZHEJIANG TECHNOLOGY 2013-06-05 CN disclosed
CN-101948382-A Synthetic method of 2-(4-alkyl substituted benzoyl) phenylformic acid UNIV ZHEJIANG TECHNOLOGY 2011-01-19 CN disclosed
EP-1496896-A4 INHIBITORS OF AKT ACTIVITY MERCK & CO INC (US) 2007-10-31 EP disclosed
US-7223738-B2 Inhibitors of Akt activity MERCK & CO., INC. (US) 2007-05-29 US disclosed
US-20050222155-A1 Inhibitors of akt activity MERCK SHARP & DOHME CORP. 2005-10-06 US disclosed
EP-1496896-A1 INHIBITORS OF AKT ACTIVITY Merck & Co., Inc. (US) 2005-01-19 EP disclosed
WO-2003086394-A1 INHIBITORS OF AKT ACTIVITY MERCK & CO., INC. (US) 2003-10-23 WO disclosed
EP-0562815-A1 Aromatic hydrocarbons separation from aromatic/non-aromatic mixtures EXXON RESEARCH AND ENGINEERING COMPANY (US) 1993-09-29 EP disclosed
US-5220106-A Organic non-quaternary clathrate salts for petroleum separation EXXON RESEARCH AND ENGINEERING COMPANY (US) 1993-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222155-A1 Inhibitors of akt activity AKT1, AKT2, AKT3 ALDH1A1 3399/4885KDM4E 1347/4885ALOX12 4445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.